Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

February 12-13, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-18, 2018

34th International Conference on Chemical Biology & Radiation Therapy

San Diego, California
August 27-28, 2018

5th International Conference on Glycobiology

Toronto, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
November 29-30, 2018

Bioinformatics Congress 2018

Dublin, Ireland

Diagnostic Biomarkers in Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in